drugset / Trial / NCT03614065

Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC

NCT03614065

RandomizedParallel-groupOpen-labelTreatment

Summary

Observe the effect os radiotherapy plus or not plus endostar in the treatment of brain metastasis in NSCLC

Timeline

Start
2017-02-21
Primary completion
2018-11
Completion
2018-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Endostar Protein / enzyme biologic